- Location
Janssen
"-
EPA Recognized Three Industrial Facilities Today with the ENERGY STAR CHP Award
Oct 10, 2014The U.S. Environmental Protection Agency (EPA) recognized three industrial facilities today with the ENERGY STAR Combined Heat and Power (CHP) Award for their highly efficient CHP systems—energy production systems that decrease energy ...
Tags: CHP systems, energy production systems, EPA
-
Imec Has Grown to Be a Multi-Disciplinary Expertise Center
Jan 21, 2014Last week nanotechnology research institute imec of Leuven, Belgium celebrated its 30th anniversary. Founded in 1984 as a non-profit organization, imec has grown to be a multi-disciplinary expertise center in the fields of semiconductor ...
Tags: FinFETs, III-V CMOS, ASML of Veldhoven, TSMC
-
Bayer HealthCare Has Failed to Win The Backing of The US FDA's Cardiovascular
Jan 20, 2014Bayer HealthCare has failed to win the backing of the US FDA's Cardiovascular and Renal Drugs Advisory Committee to expand the use of its oral anticoagulant Xarelto (rivaroxaban) 2.5 mg twice daily (BID) in combination with standard ...
Tags: FDA Panel, ACS Patients
-
Johnson & Johnson's Janssen Biotech Inc. is Showing Interest in Stem Cell Therapy
Jan 9, 2014Johnson & Johnson's Janssen Biotech Inc. is showing interest in stem cell therapy delivered to the heart via a catheter. Janssen is providing an upfront payment of $12.5 million related to Capricor Therapeutics Inc.'s CAP-1002 therapy ...
Tags: Janssen, Catheter, Stem Cell Tech
-
Johnson&Johnson Enters Collaborations with Two Canadian Drug Technology Developmen Centers
Dec 12, 2013Johnson & Johnson Innovation and its affiliate Janssen have entered into new collaborations with two Canadian early-stage drug technology development centers, NEOMED and MaRS Innovation, to discover and develop new bio/pharmaceutical ...
-
Ono Pharmaceuticals Has Elected to Amend and Expand The Existing Collaboration Agreement
Dec 12, 2013Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
-
FDA Has Approved Janssen Therapeutics' NS3/4A Protease Inhibitor 'Olysio'
Nov 25, 2013The US Food and Drug Administration (FDA) has approved Janssen Therapeutics' NS3/4A protease inhibitor 'Olysio (simeprevir)' for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with ...
-
JNJ and PCYC Have Won Approval From FDA for Their Breakthrough Therapy Imbruvica
Nov 15, 2013Johnson & Johnson (JNJ) subsidiary Janssen Biotech and Pharmacyclics (PCYC) have won approval from the US Food and Drug Administration (FDA) for their breakthrough therapy Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma ...
Tags: Johnson&Johnson, MCL Patients
-
Evotec Said a Collaboration with Johnson&Johnson Innovation for Alzheimer's Drug Discovery
Nov 12, 2013Evotec has announced a collaboration with the Johnson & Johnson Innovation Center in California to identify new targets for Alzheimer's disease drug discovery and development. Under the terms of the agreement, Janssen Pharmaceuticals ...
Tags: Evotec, Johnson, innovation, Alzheimer
-
Will It Be Apple? Samsung? Or Microsoft? Or It Will Be All of The Above
Nov 6, 2013BlackBerry's dramatic fall in the enterprise has left CIOs scrambling to pick a new mobile platform provider. Will it be Apple? Samsung? Or Microsoft? Or it will be all of the above. "The entire landscape has shifted in a very short ...
Tags: Samsung, Apple, Microsoft, Blackberry
-
Janssen-Cilag Has Submitted MAA to EMA
Nov 1, 2013Janssen-Cilag (Janssen), a subsidiary of Johnson & Johnson pharmaceutical firm, has submitted marketing authorization application (MAA) to the European Medicines Agency (EMA) for the approval of once daily oral drug ibrutinib for the ...
Tags: Blood Cancer Medicine, Medicine
-
US FDA's Antiviral Drugs Advisory Committee Has Recommended Approval
Oct 28, 2013The US FDA's Antiviral Drugs Advisory Committee has recommended approval for Medivir's investigational protease inhibitor simeprevir (TMC435) 150mg capsules for the treatment of genotype 1 chronic hepatitis C in adult patients with ...
Tags: Medivir, Hepatitis C Patients
-
Janssen Has Submitted a Marketing Authorization Application to EMA
Oct 17, 2013Janssen-Cilag (Janssen) has submitted a marketing authorization application to the European Medicines Agency (EMA) for the approval of a once-daily fixed-dose antiretroviral combination tablet of HIV-1 medicine darunavir with cobicistat. ...
Tags: European Marketing, HIV-1
-
CureVac Has Licensing Agreement with Janssen Pharmaceutical to Develop a Messenger RNA
Oct 8, 2013Germany-based clinical stage biopharmaceutical firm CureVac has entered into collaboration and licensing agreement with Janssen Pharmaceuticals to develop a messenger RNA (mRNA)-based influenza vaccine. The deal will see CureVac ...
Tags: Influenza Vaccine, Medicine
-
Trouser Specialist Gardeur Group Was Acquired by Kranzle & NRW
Sep 25, 2013GARDEUR CEO Gerhard Kränzle has signed – on behalf of Kränzle Beteiligungs GmbH and in the presence of representatives of an investment fund of the NRW.BANK – a Memorandum of Understanding on the short-notice ...
